A global call for action to combat antimicrobial resistance: Can we get it right this time?

South African Medical Journal

Volumn 104, Issue 7, 2014, Pages 478-479

  Mendelson, Marc ^a   Matsoso, Malebona Precious ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NATIONAL DEPARTMENT OF HEALTH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; DISEASE ERADICATION; DRUG RESISTANT TUBERCULOSIS; EDITORIAL; GOVERNMENT; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INFECTION; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRACTICE GUIDELINE; PREVENTION AND CONTROL; SOUTH AFRICA; HEALTH; INTERNATIONAL COOPERATION; PROGRAM DEVELOPMENT;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; GLOBAL HEALTH; HEALTH PLANNING; HUMANS; INFECTION; INTERNATIONAL COOPERATION; PROGRAM DEVELOPMENT; SOUTH AFRICA;

EID: 84903386062     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.8534     Document Type: Editorial

References (17)

1. World Health Assembly Resolution WHO 134.R13. Combating antimicrobial resistance including antibiotic resistance. http://apps.who.int/gb/ebwha/pdf_fles/EB134/B134_R13-en.pdf (accessed 2 June 2014).
2. World Health Assembly Resolution WHA51.17. Emerging and other communicable diseases: antimicrobial resistance. http://apps.who.int/medicinedocs/documents/s16334e/s16334e.pdf (accessed 2 June 2014).
3. World Health Assembly Resolution WHA58.27. Improving the containment of antimicrobial resistance. http://www.searo.who.int/entity/medicines/topics/wha_58_27.pdf (accessed 2 June 2014).
4. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10(9):597-602. [http://dx.doi.org/10.1016/S1473-3099(10)70143-2]
5. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2003;9(4):228-236. [http://dx.doi.org/10.1016/S1473-3099(09)70054-4]
6. Centers for Disease Control and Prevention, US Department of Health and Human Services. Antibiotic Resistance Treats in the United States, 2013. Atlanta, Ga: CDC, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/ (accessed 2 June 2014).
7. European Commission. Action plan against the rising threats from antimicrobial resistance. Brussels, 2011. http://ec.europa.eu/dgs/health_consumer/docs/communication_amr_2011_748_en.pdf (accessed 2 June 2014).
8. Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: Clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother 2012;67(7):1607-1615. [http://dx.doi.org/10.1093/jac/dks084]
9. Brink AJ, Coetzee J, Corcoran C, et al. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol 2013;51(1):369-372. [http://dx.doi.org/10.1128/JCM.02234-12]
10. Klopper M, Warren RM, Hayes C, et al. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis 2013;19(3):449-455. [http://dx.doi.org/10.320/EID1903.120246]
11. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Geneva: WHO, 2014.
12. World Health Organization. WHO Drug Resistance Report 2012. Geneva: WHO, 2012.
13. Dondorp AM, Yeung S, White L, et al. Artemisinin resistance: Current status and scenarios for containment. Nat Rev Microbiol 2010;8(4):272-280. [http://dx.doi.org/10.1038/nrmicro2331]
14. Duse A. Te Global Antibiotic Resistance Partnership. S Afr Med J 2011;101(8):551.
15. Mendelson M, Whitelaw A, Nicol M, Brink A. Wake up South Africa! Te antibiotic 'horse' has bolted. S Afr Med J 2012;102(7):607-608.
16. Boyles TH, Whitelaw A, Bamford C, et al. Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without afecting inpatient mortality or re-admission rates. PLoS One 2013;8(12):e79747. [http://dx.doi.org/10.1371/journal.pone.0079747]
17. Mendelson M. Patient empowerment as a driver of hand hygiene practice: Time for patients in South Africa to have their say. Southern African Journal of Infectious Diseases 2014;29(1):3-4.